Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 254

1.

Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis.

Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane JP, Hanby A, Pinder SE, Lee AH, Humphreys S, Ellis IO, Lakhani SR.

Am J Surg Pathol. 2005 Jun;29(6):734-46.

PMID:
15897740
2.

Molecular alterations in columnar cell lesions of the breast.

Dabbs DJ, Carter G, Fudge M, Peng Y, Swalsky P, Finkelstein S.

Mod Pathol. 2006 Mar;19(3):344-9.

3.

Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family.

Abdel-Fatah TM, Powe DG, Hodi Z, Reis-Filho JS, Lee AH, Ellis IO.

Am J Surg Pathol. 2008 Apr;32(4):513-23. doi: 10.1097/PAS.0b013e318161d1a5.

PMID:
18223478
4.
6.

Molecular profile of ductal carcinoma in situ of the breast in BRCA1 and BRCA2 germline mutation carriers.

van der Groep P, van Diest PJ, Menko FH, Bart J, de Vries EG, van der Wall E.

J Clin Pathol. 2009 Oct;62(10):926-30. doi: 10.1136/jcp.2009.065524. Epub 2009 Jun 18.

PMID:
19541683
7.

Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.

Shin SJ, Simpson PT, Da Silva L, Jayanthan J, Reid L, Lakhani SR, Rosen PP.

Am J Surg Pathol. 2009 Apr;33(4):496-504. doi: 10.1097/PAS.0b013e31818af361.

PMID:
19047897
8.

Molecular evolution of breast cancer.

Simpson PT, Reis-Filho JS, Gale T, Lakhani SR.

J Pathol. 2005 Jan;205(2):248-54. Review.

PMID:
15641021
9.

Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas.

Simpson PT, Reis-Filho JS, Lambros MB, Jones C, Steele D, Mackay A, Iravani M, Fenwick K, Dexter T, Jones A, Reid L, Da Silva L, Shin SJ, Hardisson D, Ashworth A, Schmitt FC, Palacios J, Lakhani SR.

J Pathol. 2008 Jul;215(3):231-44. doi: 10.1002/path.2358.

PMID:
18473330
10.

Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions.

MacGrogan G, Arnould L, de Mascarel I, Vincent-Salomon A, Penault-Llorca F, Lacroix-Triki M, Bibeau F, Baranzelli MC, Fridman V, Antoine M, Bécette V, Brouste V, Jacquemier J, Mathoulin-Pélissier S; GEFPICS group.

Histopathology. 2008 May;52(6):689-97. doi: 10.1111/j.1365-2559.2008.03016.x. Epub 2008 Apr 5.

PMID:
18397281
11.

Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.

Boecker W, Buerger H, Schmitz K, Ellis IA, van Diest PJ, Sinn HP, Geradts J, Diallo R, Poremba C, Herbst H.

J Pathol. 2001 Nov;195(4):415-21.

PMID:
11745672
12.

Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.

Hussein MR, Abd-Elwahed SR, Abdulwahed AR.

Cell Biol Int. 2008 Jun;32(6):698-707. doi: 10.1016/j.cellbi.2008.01.007. Epub 2008 Jan 25.

PMID:
18296077
13.

Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias.

Bratthauer GL, Moinfar F, Stamatakos MD, Mezzetti TP, Shekitka KM, Man YG, Tavassoli FA.

Hum Pathol. 2002 Jun;33(6):620-7.

PMID:
12152161
14.

Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.

Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM.

Breast Cancer Res. 2008;10(5):R87. doi: 10.1186/bcr2157. Epub 2008 Oct 17.

15.

Chromosomal alterations in pure nonneoplastic breast lesions: implications for breast cancer progression.

Ellsworth RE, Ellsworth DL, Weyandt JD, Fantacone-Campbell JL, Deyarmin B, Hooke JA, Shriver CD.

Ann Surg Oncol. 2010 Jun;17(6):1688-94. doi: 10.1245/s10434-010-0910-x. Epub 2010 Jan 27.

PMID:
20107913
16.

Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ.

Boecker W, Moll R, Dervan P, Buerger H, Poremba C, Diallo RI, Herbst H, Schmidt A, Lerch MM, Buchwalow IB.

J Pathol. 2002 Dec;198(4):458-67.

PMID:
12434415
17.

Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast.

Hanley K, Wang J, Bourne P, Yang Q, Gao AC, Lyman G, Tang P.

Hum Pathol. 2008 Mar;39(3):386-92. doi: 10.1016/j.humpath.2007.07.007. Epub 2008 Jan 9.

PMID:
18187183
18.

Breast carcinogenesis. Transition from hyperplasia to invasive lesions.

Meteoglu I, Dikicioglu E, Erkus M, Culhaci N, Kacar F, Ozkara E, Uyar M.

Saudi Med J. 2005 Dec;26(12):1889-96.

PMID:
16380768
19.
20.

Nuclear cytometric changes in breast carcinogenesis.

Mommers EC, Poulin N, Sangulin J, Meijer CJ, Baak JP, van Diest PJ.

J Pathol. 2001 Jan;193(1):33-9.

PMID:
11169513

Supplemental Content

Support Center